419
Views
6
CrossRef citations to date
0
Altmetric
Original

Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells

, , , , , , , , & show all
Pages 615-629 | Received 18 Feb 2005, Accepted 27 Aug 2005, Published online: 09 Jul 2009

References

  • Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S. the Glioma Outcomes Investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcome Project. Journal of Neurosurgery 2003; 99: 467–473
  • Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neurooncology 1999; 1: 124–137
  • Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnel TJ, Steck KD, Levin VA, Yung WK. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Research 1996; 56: 694–699
  • Kock H, Harris MP, Anderson SC, Machemer T, Hancock W, Sutjipto S, Wills KN, Gregory RJ, Shepard HM, Westphal M, Maneval DC. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. International Journal of Cancer 1996; 67: 808–815
  • Lang FF, Yung WK, Sawaya R, Tofilon PJ. Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 1999; 45: 1093–1104
  • Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological and clinical results. Journal of Clinical Oncology 2003; 21: 2508–2518
  • Uzuka T, Tanaka R, Takahashi H, Kakinuma K, Matsuda J, Kato K. Planning of hyperthermic treatment for malignant glioma using computer simulation. International Journal of Hyperthermia 2001; 17: 114–122
  • Komata T, Kanzawa T, Nashimoto T, Aoki H, Endo S, Nameta M, Takahashi H, Yamamoto T, Kondo S, Tanaka R. Mild heat shock induces autophagic growth arrest, but not apoptosis in U251-MG and U87-MG human malignant glioma cells. Journal of Neurooncology 2004; 68: 101–111
  • Komata T, Kondo Y, Koga S, Ko SC, Chung LWK, Kondo S. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Therapy 2000; 7: 2071–2079
  • Kondo Y, Komata T, Kondo S. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas. International Journal of Oncology 2001; 18: 1287–1292
  • Yasumoto J, Kirita T, Takahashi A, Ohnishi K, Imai Y, Yuki K, Ohnishi T. Apoptosis-related gene expression after hyperthermia in human tongue squamous cell carcinoma cells harboring wild-type or mutated-type p53. Cancer Letters 2004; 204: 41–51
  • Ohnishi T, Ohnishi K, Takahashi A. Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53. BMC Biotechnology 2002; 2: 6
  • Islam MS, Mitsuhashi N, Akimoto T, Sakurai H, Hasegawa M, Ishikawa H, Niibe H. Hyperthermia-induced apoptosis in two rat yolk sac tumor cell lines with different radiothermosensitivity in vitro. Oncology Reports 2001; 8: 501–507
  • Fuse T, Yoon KW, Kato T, Yamada K. Heat-induced apoptosis in human glioblastoma cell line A172. Neurosurgery 1998; 42: 843–849
  • Kato K, Hasegawa K, Goto S, Inagguma Y. Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. Journal of Biological Chemistry 1994; 269: 11274–11278
  • Ohnishi T, Matsumoto H, Takahashi A, Shimura M, Majima HJ. Accumulation of mutant p53 and hsp72 by heat treatment, and their association in a human glioblastoma cell line. International Journal of Hyperthermia 1995; 11: 663–671
  • Ahern TJ, Casal JI, Petsko GA, Klibanov AM. Control of oligomeric enzyme thermostability by protein engineering. Proceedings of the National Academy of Sciences (USA) 1987; 84: 675–679
  • Arlander SJ, Eapen AK, Vroman BT, McDonald RJ, Toft DO, Karnitz LM. Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress. Journal of Biological Chemistry 2003; 278: 52572–52577
  • Machida H, Matsumoto Y, Shirai M, Kubota N. Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation. International Journal of Radiation Biology 2003; 79: 973–980
  • Guan J, Stavridi E, Leeper DB, Iliakis G. Effects of hyperthermia on p53 protein expression and activity. Journal of Cell Physiology 2002; 190: 365–374
  • Capoulade C, Bressac-de Paillerets B, Lefrere I, Ronsin M, Feunteun J, Tursz T, Wiels J. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Oncogene 1998; 16: 1603–1610
  • Momand J, Jund D, Wilczyinski S, Niland J. The MDM2 gene amplification database. Nucleic Acids Research 1998; 26: 3453–3459
  • Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Current Biology 2002; 14: 727–733
  • Zhou X, Wang XW, Xu L, Hagiwara K, Nagashima M, Wolkowicz R, Zurer I, Rotter V, Harris CC. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis. Cancer Research 1999; 59: 843–848

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.